Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Serrano

Showing results (211-220 of 223) with videos related to

Pageof 23
Sort By:
The Journal of Investigative Dermatology|September 17, 2010
Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approachJúlia M Sánchez-Schmidt, Rocío Salgado, Octavio Servitje, et al.
Haematologica|May 7, 2011
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapyTeresa M Cardesa-Salzmann, Luis Colomo, Gonzalo Gutierrez, et al.
Frontiers in Immunology|January 23, 2026
Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamicsLaura Martín-Pedraza, Eulalia Rodríguez-Martín, Erick De La Torre-Tarazona, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study)Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryBlanca Espinet, Ana Ferrer, Beatriz Bellosillo, et al.
The American Journal of Surgical Pathology|January 26, 2011
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell componentCarlo Visco, Sylvia Hoeller, Jeffrey T Malik, et al.
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
Revista Espanola De Salud Publica|September 5, 2018
[HIV in Spain 2017: policies for a new management of chronicity beyond virological control]Julia Del Amo, Colin Campbell, Gemma Navarro, et al.
Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.
Pageof 23

Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
The Journal of Investigative Dermatology|September 17, 2010
Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approachJúlia M Sánchez-Schmidt, Rocío Salgado, Octavio Servitje, et al.
Haematologica|May 7, 2011
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapyTeresa M Cardesa-Salzmann, Luis Colomo, Gonzalo Gutierrez, et al.
Frontiers in Immunology|January 23, 2026
Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamicsLaura Martín-Pedraza, Eulalia Rodríguez-Martín, Erick De La Torre-Tarazona, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study)Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryBlanca Espinet, Ana Ferrer, Beatriz Bellosillo, et al.
The American Journal of Surgical Pathology|January 26, 2011
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell componentCarlo Visco, Sylvia Hoeller, Jeffrey T Malik, et al.
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
The Journal of Clinical Investigation|June 21, 2016
IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infectionSouheil-Antoine Younes, Michael L Freeman, Joseph C Mudd, et al.
Revista Espanola De Salud Publica|September 5, 2018
[HIV in Spain 2017: policies for a new management of chronicity beyond virological control]Julia Del Amo, Colin Campbell, Gemma Navarro, et al.
Blood|May 19, 2010
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma GroupMarta Salido, Cristina Baró, David Oscier, et al.
Pageof 23